Fri, Nov 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains 1.32% in April (3.24% YTD), Healthcare & Biotechnology index best performer with +3.45% (6.10% YTD)

Monday, May 16, 2011
Opalesque Industry Update – Hedge funds gained 1.32% in April according to the Barclay Hedge Fund Index compiled by BarclayHedge. Year-to-date the Index is up 3.24%.

“Higher prices for equities and bonds in April provided an accommodating environment for most hedge fund strategies,” says Sol Waksman, founder and president of BarclayHedge.

“Strength in the bond market despite US dollar weakness and a well bid equity market took many participants by surprise,” says Waksman. “Yet looking at the positive returns of fixed income-based strategies in April, it appears that hedge fund managers were not caught unawares.

All but two of Barclay’s 18 hedge fund indices had gains in April. The Barclay Healthcare & Biotechnology Index was up 3.45%, Technology gained 2.67%, Global Macro was up 1.96%, Emerging Markets gained 1.82%, and the European Equities Index rose 1.78%.

“Hedge funds have made steady progress since September of 2010, as evidenced by eight straight months of gains for the Barclay Hedge Fund Index,” says Waksman.

The Equity Short Bias Index has lost ground for eight months in a row and gave up another 1.94% in April. Equity Short Bias is down 7.66% year-to-date.

The Barclay Fund of Funds Index gained 1.14% in April and is up 1.98% in 2011.

(press release)

Performance tables: Source

BarclayHedge was founded in 1985 and actively tracks more than 6,000 hedge funds, funds of hedge funds, and managed futures programs. Each month Barclay provides updated performance rankings for 38 Hedge Fund categories and 16 CTA categories.

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Unlucky Paulson & Co. rebrands $1.6bn Recovery Fund after 13% drop[more]

    From Businessweek.com: A maturing U.S. economic recovery is prompting Paulson & Co. to change course. The $19 billion hedge fund firm, led by billionaire John Paulson, told investors on a conference call this month that the Paulson Recovery Fund will be renamed Paulson Special Situations Fund on Jan

  2. Opalesque Roundtable: Islamic Finance races ahead with Sukuk, the first managed account platform, and foreign demand[more]

    Komfie Manalo, Opalesque Asia: A number of developments took place within Islamic finance in the past years, including the launch of a Islamic managed account platform and the further growth of the sukuk space that saw this instrument evolve from being a type of an ABS security that was rarely

  3. CTAs , event-driven strategies lead hedge funds recovery in mid-November[more]

    Komfie Manalo, Opalesque Asia: November’s performance proves to be in sharp contrast to the previous month, with equities further consolidating their upswing last week, according to the latest Lyxor Asset Management’s Weekly Brief. CTA funds als

  4. Fund Profile - A complex hedge fund strategy works for United Technologies[more]

    From Institutionalinvestor.com: Reports that portable alpha is dead have been greatly exaggerated, as Mark Twain might have phrased it. Another Connecticut Yankee, giant United Technologies Corp., is gearing up to grow its successful, nearly decade-long portable-alpha program. The UTC strategy took

  5. Opalesque Exclusive: The unintended consequences of Basel III[more]

    Benedicte Gravrand, Opalesque Geneva: Bijesh Amin, co-founder and managing director of Indus Valley Partners (IVP), a technology solutions and services firm focused on the alternative asset management industry, has recently observed